NON-ALCOHOLIC FATTY LIVER DISEASE

This study is testing whether an oral medication called MN-001 can reduce liver fat and lower triglyceride levels in people who have non-alcoholic fatty liver disease, type 2 diabetes, and high triglycerides. About 40 participants will take either the study drug or a placebo pill…

This study is testing whether an investigational drug called GSK4532990 can reduce liver scarring and inflammation in adults with advanced NASH, a serious form of fatty liver disease. About 284 participants with confirmed liver damage will receive either the drug or a placebo for…

This study is testing whether an investigational drug called efinopegdutide can help treat a serious form of fatty liver disease called MASH that has progressed to cause permanent scarring (cirrhosis). About 80 adults with this condition will receive either the drug or a placebo …

This study aimed to test a new type of ultrasound device for detecting and measuring fat in the liver. Researchers planned to compare the device's accuracy to the current standard method, an MRI scan. The trial was withdrawn before any participants were enrolled.

This 2-year study is testing whether a diet very low in added sugars can prevent non-alcoholic fatty liver disease (NAFLD) in Hispanic children who are at high risk. Researchers are working with 103 children ages 6-9 who have overweight or obesity but don't yet have liver problem…

This study aims to understand if adolescents and young adults with Polycystic Ovary Syndrome (PCOS) are more likely to have high liver fat and related metabolic problems like insulin resistance. Researchers will compare 40 young people with PCOS to 40 without it, using scans and …

This study aims to understand why storing fat around organs like the liver affects some people's health more than others, potentially leading to conditions like diabetes and heart disease. Researchers are comparing lean and obese individuals, some with and some without metabolic …

This study aims to check how reliable and repeatable results are from a non-invasive liver scanning device called FibroScan. It will involve 108 adult patients with fatty liver disease, who will have multiple scans over two visits to see if different operators and different days …

This study aims to find out how many adults in Belgium have a common liver condition called NAFLD, which is linked to being overweight. Researchers will screen 10,000 people through their family doctors using surveys and non-invasive methods. The goal is to understand the scale o…